Search

Search Results

• Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project

  L. Dalle Carbonare, F. Bertoldo, V. Lo Cascio

  54-64

  https://doi.org/10.4081/reumatismo.2009.54

  1412

  PDF: 1120

• CO:11:3 | Belimumab for lupus nephritis patients with poor kidney function: a post-hoc analysis of the bliss-ln trial Giacomo Emmi^1|2, Ersilia Lucenteforte³, Giorgio Limoncella³, Emanuele Chiara^1|2, Marta Calatroni^4|5, Gabriella Moroni^4|5 | ¹Clinical Medicine and Rheumatology Unit, Cattinara University Hospital, Trieste, Italy; ²Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy; ³Department of Statistics, Informatics and Applications Giuseppe Parenti, University of Florence, Florence, Italy; ⁴Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; ⁵Nephrology and Dialysis Division, IRCCS Humanitas Research Hospital, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2278

  15

• PO:16:235 | Anifrolumab in systemic lupus erythematosus: real-life experience of a single-center cohort Filippo Vesentini¹, Luca Iaccarino¹, Federico Arru², Greta Hulej¹, Anna Giorgia Osele¹, Noemi Merra¹, Davide Ragno¹, Andrea Doria¹, Margherita Zen¹ | ¹UOC Reumatologia, Dipartimento di Medicina DIMED, Università degli Studi di Padova; ²UO Medicina, ASL 3 Nuoro, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2162

  125

• PO:26:087 | Rituximab versus glucocorticoids for IgG4-related disease: a European retrospective multi-center study of 167 patients Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Jasmin Mahajne¹, Veronica Batani¹, Lorenzo Dagna¹, Emanuel Della-Torre¹ | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale san Raffaele Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Stavanger, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University Munich, Munich Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2355

  47

• Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis

  M. Fabris, L. Quartuccio, S. Lombardi, M. Benucci, M. Manfredi, M. Saracco, F. Atzeni, P. Morassi, M.A. Cimmino, E. Pontarini, C. Fabro, R. Pellerito, P. Sarzi-Puttini, M. Cutolo, A. Carletto, L.M. Bambara, F. Fischetti, F. Curcio, E. Tonutti, S. De VIta

  253-258

  https://doi.org/10.4081/reumatismo.2010.253

  2366

  PDF: 901

• Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies

  I. Cavazzana, F. Franceschini, E. Danieli, M. Frassi, M. Vianelli, R. Gorla, P. Airò, R. Cattaneo

  267-272

  https://doi.org/10.4081/reumatismo.2005.267

  1219

  PDF: 1838

• PO:15:216 | Safety and Efficacy of a single dose of Rituximab to manage Pregnancy-Related Severe Flare of Systemic Lupus Erythematosus: A Case Report Eugenio Capparelli¹, Daniela Bompane¹, Eleonora Zaccara¹, Laura Castelnovo¹, Antonio Tamburello¹, Antonino Mazzone², Paola Faggioli¹ | ¹UOC Reumatologia, ASST Ovest Milanese, Legnano, Milano, Italy; ²UOC Medicina Interna, ASST Ovest Milanese, Legnano, Milano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2329

  25

• Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

  M. Filippini, C. Bazzani, S. Zingarelli, T. Ziglioli, M. Nuzzo, M. Vianelli, C. Biasini Rebaioli, R. Cattaneo, R. Gorla

  41-49

  https://doi.org/10.4081/reumatismo.2008.41

  1271

  PDF: 856

• PO:18:276 | Use of anifrolumab in the treatment of difficult-to-treat manifestations in systemic lupus erythematosus Antonella Grimaldi¹, Giuseppe Alessandrini², Laura Quarta¹, Maria Rita Ricciardi¹, Daniela Costanza¹, Clara Minerba¹, Eugenio Quarta¹ | ¹UOC Reumatologia Verona; ²Specialista Dermatologo in Libera Professione, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2170

  153

• S02:5 | Combined anti-IL-5/IL-5r and dupilumab therapy in eosinophilic granulomatosis with polyangiitis: a European retrospective study Miriam Guerini¹, Pavel Novikov², Roberto Padoan³, Georgina Espigol Frigolé⁴, Jan Willem Cohen Tervaert⁵, Vincent Grobost⁶, Laurent Guilleminault⁷, Jan Walter Schroeder⁸, Bernhard Hellmich⁹, Joana Martins Martinho¹⁰, Camillo Ribi¹¹, Matthieu Groh¹², Benjamin Terrier¹³. | ¹IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy; ²Sechenov University, Moscow, Russia; ³University of Padova, Padova, Italy; ⁴Hospital Clinic, University of Barcelona, Barcelona, Spain; ⁵University of Alberta, Edmonton, Canada; ⁶CHU Estaing Clermont-Ferrand France; ⁷Toulouse University Toulouse France; ⁸ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; ⁹Medius Kliniken Kirchheim-Teck Germany; ¹⁰ULS Santa Maria, Lisbon, Portugal; ¹¹Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; ¹²Hopital Foch, Suresnes, France; ¹³Service de Medecine interne, Hopital Cochin, AP-HP, Paris, France.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2101

  182
• 

  The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

  Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino

  23-07-2025

  https://doi.org/10.4081/reumatismo.2025.1830

  1686

  PDF: 163

• CO:01:1 | Efficacy and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients Marco Lanzillotta¹, Jens Vikse², Elisabetta Goni³, Veronica Batani¹, Jasmin Mahajne¹, Lorenzo Dagna¹, Emanuel Della Torre¹. | ¹Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; ²Department of Rheumatology, Stavanger University Hospital, Norway; ³Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1961

  271

• Efficacy of immunosoppressive therapy and steroid sparing effect in interstitial lung disease associated to antisynthetase syndrome

  N. Franzolini, L. Quartuccio, G. De Marchi, S. De Vita

  202-208

  https://doi.org/10.4081/reumatismo.2007.202

  1497

  PDF: 1318

• PO:15:212 | Anifrolumab induces a rapid improvement in joint inflammation in Systemic Lupus Erythematosus patients: an ultrasonographic study Valeria Moretti, Fulvia Ceccarelli, Claudia Ciancarella, Valerio Fiorilli, Francesca Romana Spinelli, Fabrizio Conti | Sapienza Università di Roma, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2326

  12
• 

  Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?

  M. Rossini, O Viapiana, G. Orsolini, E. Fracassi, L. Idolazzi, D. Gatti, S. Adami, M. Govoni

  285-303

  31-03-2015

  https://doi.org/10.4081/reumatismo.2014.799

  2734

  PDF: 2378

• CONVENTIONAL THERAPIES FOR PSORIASIS

  A. Rebora

  77-80

  https://doi.org/10.4081/reumatismo.2007.1s.77

  1002

  PDF: 972
• 

  Baricitinib in polymyalgia rheumatica and giant cell arteritis: report of six cases

  Dario Camellino, Christian Dejaco, Franco Martini, Renzo Cosso, Gerolamo Bianchi

  28-10-2024

  https://doi.org/10.4081/reumatismo.2024.1796

  2119

  PDF: 475
• 

  Evaluation of tramadol/paracetamol 75 mg/650 mg combination therapy for early-stage knee osteoarthritis: a retrospective observational study

  Alessandro Conforti, Cosimo Ruggiero, Nastasja Palombi, Filippo Messina, Marco Bonifacio, Linda Lucchetti, Marco Ruggiero, Giuseppe La Cava, Roberto Piazza, Mario Mangrella

  23-07-2025

  https://doi.org/10.4081/reumatismo.2025.1872

  1700

  PDF: 329
• 

  The use of rituximab in idiopathic inflammatory myopathies: description of a monocentric cohort and review of the literature

  S. Barsotti, E. Cioffi, A. Tripoli, A. Tavoni, A. d’Ascanio, M. Mosca, R. Neri

  78-84

  06-07-2018

  https://doi.org/10.4081/reumatismo.2018.1011

  2860

  PDF: 1473

• PO:20:006 | Efficacy of denosumab in glucocorticoid-induced osteoporosis patients with prior exposure to intravenous aminobisphosphonates Kiren Khalid¹, Alessandro Giollo¹, Mariangela Salvato¹, Francesca Frizzera¹, Lorenzo Di Luozzo¹, Bernd Raffeiner², Andrea Doria¹ | ¹Rheumatology Unit, Department of Medicine - DIMED, University of Padova, Padova, Italy; ²Department of Rheumatology, Bolzano Central Hospital, Bolzano, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2341

  13

• Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis

  C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi

  32-37

  https://doi.org/10.4081/reumatismo.2007.32

  1884

  PDF: 835
• 

  Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review

  Carlo Perricone, Roberto Dal Pozzolo, Giacomo Cafaro, Santina Calvacchi, Lorenza Bruno, Francesco Tromby, Anna Colangelo, Roberto Gerli, Elena Bartoloni

  25-10-2024

  https://doi.org/10.4081/reumatismo.2024.1685

  2405

  PDF: 713

• PO:18:264 | Anifrolumab in Systemic Lupus Erythematosus: Bridging Clinical Trial Data with Real-World Evidence Giulia Cassone², Filippo Santoro¹, Caterina Vacchi², Dilia Giuggioli², Chiara Cabassi¹ | ¹UOC Reumatologia, AOU Policlinico di Modena, Università degli studi di Modena e Reggio Emilia Modena e Reggio Emilia, Italy; ²UOC Reumatologia, AOU Policlinico di Modena Modena, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2337

  55
• 

  Effects of secukinumab on serum adipocytokines: preliminary data

  A. Fassio, D. Gatti, P. Gisondi, G. Girolomoni, O. Viapiana, A. Giollo, M. Zamboni, M. Rossini, L. Idolazzi

  105-110

  21-09-2017

  https://doi.org/10.4081/reumatismo.2017.953

  3050

  PDF: 1612

• Vitamin D and fractures: a sistematic review

  O. Viapiana, D. Gatti, M. Rossini, L. Idolazzi, E. Fracassi, S. Adami

  15-19

  https://doi.org/10.4081/reumatismo.2007.15

  1565

  PDF: 1639
• 

  Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy

  M. Tasso, N. Bertolini, E. Mostacciuolo, S. Passavanti, J.M.E. Luppino, A. Del Puente, R. Peluso, F. Santelli, R. Scarpa, L. Costa, F. Caso

  29-12-2022

  https://doi.org/10.4081/reumatismo.2022.1511

  2168

  PDF: 997

• Intra-articulaar treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up

  A. Migliore, S. Tormenta, C. Valente, U. Massafra, L.S. Martin Martin, E. Carmenini, A. Bernardini, A. Alimonti

  36-43

  https://doi.org/10.4081/reumatismo.2005.36

  1030

  PDF: 1732

• PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2043

  133

• Efficacy of Cellfood®’s therapy (deutrosulfazyme) in fibromyalgia

  M.E. Nieddu, L. Menza, F. Baldi, B. Frediani, R. marcolongo

  316-321

  https://doi.org/10.4081/reumatismo.2007.316

  2654

  PDF: 1706

• Approved indications and other possible utilizations of anti-TNFa biologic drugs

  W. Grassi, C. Montecucco

  30-33

  https://doi.org/10.4081/reumatismo.2005.4s.30

  1327

  PDF: 926

• PO:07:103 | Tocilizumab use in patients with rheumatoid arthritis and malignancy: a monocentric experience Vittorio Dibenedetto^1|2|3, Nicola Farina^1|2, Nicola Boffini^1|2, Alessandro Tomelleri^1|2, Adriana Cariddi^1|2, Elena Baldissera^1|2, Marco Matucci-Cerinic^1|2|3, Lorenzo Dagna^1|2|3. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and Ageing Intitiative ^INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; ³Vita-Salute San Raffaele University, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2021

  128

• PO:27:108 | Delphi consensus on the shared management of patients with rheumatologic and oncologic diseases Luigi De Marco¹, Augusta Ortolan², Antonio Carletto³, Fulvia Ceccarelli⁴, Lorenzo Dagna⁵, Ginevra De Marchi⁶, Ennio Giulio Favalli⁷, Alessandro Inno⁸, Giuseppe Lopalco⁹, Francesco Ciccia¹⁰, Ennio Lubrano¹¹, Luca Quartuccio¹², Immacolata Prevete¹³, Roberta Ramonda¹⁴, Nicola Silvestris¹⁵, Marcello Tiseo¹⁶, Michelina Turri¹, Maria Sole Chimenti¹ | ¹Reumatologia, allergologia e immunologia clinica, dipartimento di medicina dei sistemi, Università di Roma Tor Vergata; ²UOC Reumatologia e immunologia clinica, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma; ³Unità di Reumatologia, Dipartimento di medicina, AOUI università di Verona; ⁴Reumatologia, Dipartimento di Scienze Cliniche, Anestesiologiche Internistiche e Cardiovascolari, Sapienza Università di Roma; ⁵Unità di Immunologia, Reumatologia, Allergologia e malattie rare UnIRar, IRCSS San Raffaele, Milano; ⁶Unità di Reumatologia, Dipartimento di medicina, Azienda Sanitaria Universitaria Integrata, Università di Udine; ⁷Dipartimento di Reumatologia e scienze mediche, Istituto Gaetano Pini, Università di Milano; ⁸Oncologia Medica, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella (VR); ⁹UOC Reumatologia, Dipartimento di Medicina di Precisione e Rigenerativa e Area Ionica, Università di Bari "Aldo Moro"; ¹⁰Unità di Reumatologia, Dipartimento di Medicina di Precisione, Università della Campania L. Vanvitelli, Napoli; ¹¹Unità di Reumatologia, Università degli Studi del Molise, Campobasso; ¹²SOC Clinica Reumatologica - ASUFC, Dipartimento di Medicina, Università degli Studi di Udine; ¹³UOC Reumatologia Azienda Ospedaliera San Camillo-Forlanini, Roma; ¹⁴UOC di Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; ¹⁵UOC Oncologia Medica e Dipartimento Area Medica - IRCCS Istituto Tumori Giovanni Paolo II, Bari; ¹⁶UOC di Oncologia Medica, Azienda Ospedaliero-Universitaria di Parma, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2195

  137

• PO:17:259 | Anifrolumab: a new management of SLE Giorgia Montozzi¹, Chiara Cocco¹, Ramona Santangeli¹, Lucia Gamba¹, Paola Fioretti¹, Letizia Curina¹, Chiara Guidoni¹, Edoardo Cipolletta³, Gianluca Moroncini² | ¹Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; ²Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; ³Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2336

  38

• Phytothermotherapy with fermenting alpine grass in knee osteoarthritis: mid-long term results

  R. Miori, G. Paolazzi, R. Albertazzi, P. Manica, S. Inchiostro, F. Bonella, R. Bortolotti, A.M. Mariani, P. Bortoli

  282-289

  https://doi.org/10.4081/reumatismo.2008.282

  1032

  PDF: 878
• 

  Small molecules in idiopathic inflammatory myopathies: a systematic review and a multicenter case series about Janus kinase inhibitors and apremilast

  Chiara Rizzo, Silvia Grazzini, Edoardo Conticini, Hector Chinoy, Roberto D’Alessandro, Federica Camarda, Luca Cantarini, Bruno Frediani, Giuliana Guggino, Lidia La Barbera

  13-01-2025

  https://doi.org/10.4081/reumatismo.2025.1718

  1965

  PDF: 304

  SUPPLEMENTARY MATERIAL: 158

• Anabolic effects and inhibition of interleukin 6 production induced by neridronate on human osteoblasts

  A. Spreafico, B. Frediani, C. Capperucci, D. Gambera, P. Ferrata, F. Baldi, F. Chellini, S. Niccolini, L. Bocchi, R. Marcolongo

  288-300

  https://doi.org/10.4081/reumatismo.2006.288

  1391

  PDF: 802

• PO:38:283 | Accuracy of chatgpt 4 omni in providing clinical recommendations in musculoskeletal care: a valuable support for clinicians and patients? Dario Taborelli¹, Silvia Negro¹, Federico Padovani², Tiziano Innocenti^1|3, Stefano Salvioli¹ | ¹DINOGMI, Università di Genova, Savona; ²Dipartimento di Neuroscienze e Riabilitazione, Università di Ferrara; ³GIMBE Foundation, Bologna, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2226

  131

• PO:35:234 | Sustained Vasculitis Quiescence and CS Reduction with Mepolizumab 100 mg Francesca Mascia¹, Angelo Fassio², Marco Zurlo¹, Davide Chesini³, Francesco Pollastri², Giovanni Adami², Davide Gatti⁴, Maurizio Rossini⁴, Matteo Maule⁵, Gianentrico Senna¹, Marco Caminati¹ | ¹University of Verona - Allergology and Clinical Immunology Verona, Italy; ²Policlinico G. B. Rossi - Rheumatology Verona, Italy; ³University of Verona - Faculty of Medicine and Surgery Verona, Italy; ⁴University of Verona - Rheumatology Verona, Italy; ⁵Policlinico G. B. Rossi - Allergology and Clinical Immunology Verona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2387

  14

• Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience

  M. Taraborelli, L. Andreoli, S. Archetti, M. Ferrari, R. Cattaneo, A. Tincani

  98-106

  https://doi.org/10.4081/reumatismo.2009.98

  1331

  PDF: 1266

• PO:07:099 | Survival on therapy of certolizumab pegol in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: 8-year data from an Italian multicenter register Maria Manara¹, Gilberto Cincinelli^1|2, Marco Fornaro³, Simone Perniola⁴, Elisa Gremese⁵, Chiara Bazzani⁶, Serena Bugatti⁷, Francesca Romana Spinelli⁸, Rosario Foti⁹, Marco Sebastiani¹⁰, Alberto Cauli¹¹, Fabiola Atzeni¹², Giovanni Lapadula¹³, Gianfranco Ferraccioli¹⁴, Fabrizio Conti⁸, Florenzo Iannone³, Roberto Caporali^1|2 | ¹Department of Rheumatology and Medical Sciences, ASST G. Pini-CTO Milano; ²Department of Clinical Sciences and Community Health, University of Milan; ³Department of Precision and Regenerative Medicine and Ionian Area, University of Bari; ⁴Clinical Immunology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma; ⁵Rheumatology and Clinical Immunology, IRCCS Humanitas Research Hospital, Rozzano (MI); ⁶Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili Brescia; ⁷Department of Internal Medicine and Therapeutics, Università di Pavia; ⁸Rheumatology Unit, Dipartimento Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza University, Roma; ⁹Rheumatology Unit, San Marco Hospital, Policlinico University of Catania; ¹⁰Rheumatology Unit, AUSL Piacenza, University of Parma; ¹¹UOC di Reumatologia, Dipartimento di Scienze Mediche e Sanità Pubblica, Azienda Ospedaliero-Universitaria di Cagliari; ¹²Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina; ¹³Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Bari; ¹⁴Department of Medicine, Università Cattolica del Sacro Cuore, Fondazione IRCCS Policlinico Gemelli, Roma, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2137

  146

• PO:02:030 | Retention Rate of Non-anti-TNF Therapies and primary failure in monocentric cohort of patients with Psoriatic Arthritis Alba Chiara Pozzi¹, Sofia Barezzani², Andrea Galli², Cesare Tomasi¹, Micol Frassi¹, Ilaria Cavazzana¹, Franco Franceschini¹ | ¹Rheumatology and Clinical Immunology Unit ERN-ReCONNECT, ASST Spedali Civili, University of Brescia Brescia, Italy; ²Facoltà di Medicina e Chirurgia, University of Brescia Brescia, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2288

  16

• Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the litterature and personal experience

  V. Gerloni, I. Pontikaki, M Gattinara, F. Fantini

  244-261

  https://doi.org/10.4081/reumatismo.2007.244

  1456

  PDF: 1192

• PO:26:092 | Early antiproteinuric effect of voclosporine in patients with lupus nephritis in real life setting: preliminary results from the VoRLiSS (Voclosporine in Real Life Setting Study) Aurora Di Gregorio¹, Marta Calatroni², Marco Allinovi³, Alessandra Bortoluzzi⁴, Giorgio Buscetta⁵, Rossella De Angelis⁶, Ginevra De Marchi⁷, Giacomo Emmi⁸, Pasquale Esposito⁹, Paride Fenaroli¹⁰, Micaela Fredi¹¹, Giovanni Orsolini¹², Giulia Pazzola¹³, Domenico Santoro¹⁴, Andrea Doria¹, Gabriella Moroni², Luca Iaccarino¹ | ¹Azienda Ospedaliera Universitaria Padova, Italy; ²Ospedale IRCCS Humanitas Milano, Italy; ³Azienda Ospedaliero Universitaria Careggi Firenze, Italy; ⁴Azienda Ospedaliero Universitaria di Ferrara, Italy; ⁵Policlinico Universitario Paolo Giaccone Palermo, Italy; ⁶Università Politecnica delle Marche Ancona, Italy; ⁷Università di Udine, Italy; ⁸Università di Trieste, Italy; ⁹Università di Genova, Italy; ¹⁰Unità di Nefrologia AUSL IRCCS di Reggio Emilia, Italy; ¹¹Università di Brescia, Italy; ¹²Università di Verona Verona, Italy; ¹³Università di Reggio Emilia, Italy; ¹⁴Azienda Ospedaliera Universitaria G. Martino di Messina, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2356

  29

• Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy

  A. Fassio, G. Porciello, G. Carioli, E. Palumbo, S. Vitale, A. Luongo, C. Montagnese, M. Prete, M. Grimaldi, R. Pica, E. Rotondo, L. Falzone, I. Calabrese, A. Minopoli, B. Grilli, M. Cuomo, P.C. Fiorillo, C. Evangelista, E. Cavalcanti, M. De Laurentiis, D. Cianniello, C. Pacilio, M. Pinto, G. Thomas, M. Rinaldo, M. D’Aiuto, D. Serraino, S. Massarut, A. Steffan, F. Ferraù, R. Rossello, F. Messina, F. Catalano, G. Adami, F. Bertoldo, M. Libra, A. Crispo, E. Celentano, C. La Vecchia, L.S.A. Augustin, D. Gatti

  22-03-2024

  https://doi.org/10.4081/reumatismo.2024.1632

  1313

  PDF: 828

• PO:02:018 | After-SECs: clinical predictors of secukinumab retention in psoriatic arthritis patients with inadequate response to anti-tumor necrosis factor therapy Francesco Cristiano¹, Davide Gaspare Patti¹, Valentina Boni¹, Stefano Di Murro¹, Cesare Gavotti¹, Roberta Masnata¹, Giulia Calabrese², Gerlando Natalello², Giusy Peluso², Augusta Ortolan^1|2, Enrico De Lorenzis^1|2, Maria Antonietta D'Agostino^1|2. | ¹Università Cattolica del Sacro Cuore, Roma, Italy; ²Divisione di Reumatologia ed Immunologia clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2009

  144

• PO:29:138 | Cetylated fatty acids and fibromyalgia: efficacy and tolerability in a prospective study Anna Capogna¹, Marco Bardelli¹, Luca Cantarini¹, Bruno Frediani¹ | ¹UOC Reumatologia, Dipartimento di Scienze mediche, chirurgiche e neuroscienze, Università degli Studi di Siena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2200

  140

• Fish oil supplementation in rheumatoid arthritis

  C. Sales, F. Oliviero, P. Spinella

  174-179

  https://doi.org/10.4081/reumatismo.2008.174

  2062

  PDF: 1373

• PO:10:157 | Sjögren’s syndrome with cryoglobulinemia associated with POEMS syndrome Andrea Mazzon¹, Elena Bianchi¹, Virginia Berlengiero¹, Luca Cantarini¹, Bruno Frediani¹, Enrico Selvi¹ | ¹Azienda Ospedaliera Universitaria Senese Le Scotte, Siena, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2150

  148

• TNFa inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects

  I. Cavazzana, F. Bobbio-Pallavicini, C. Bazzani, E. Bravi, S. Zingarelli, A. Ceribelli, R. Caporali, R. Cattaneo, F. Franceschini, C. Montecucco

  275-282

  https://doi.org/10.4081/reumatismo.2006.275

  1210

  PDF: 1001
• 

  Long-term efficacy of intra-articular viscosupplementation in delaying hip osteoarthritis radiographic progression: a retrospective, non-controlled study from the ANTIAGE registry

  Alberto Migliore, Nazzareno Iannarelli, Antonio Devito, Raffaele Saporito, Luca Saccone, Irene Beriotto, Michele Grassi, Eugenio Cunego, Annamaria Paglionico, Sandro Tormenta

  25-02-2026

  https://doi.org/10.4081/reumatismo.2026.1917

  719

  PDF: 74